Posts

PCORI’s mandate is to improve the quality and relevance of evidence that can help patients, caregivers, clinicians and others make better-informed health or healthcare decisions. Our Evidence Updates are one…

WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and projects through 10 funding opportunities. Five of these PCORI Funding Announcements (PFAs) are…

WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $80.5 million to support four new, ambitious patient-centered comparative clinical effectiveness research (CER) studies focused on…

WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling $225 million, which include $207 million to support 20 new patient-centered comparative clinical…

WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) 2023 Annual Meeting is taking place virtually and in-person Oct. 4-5 in Washington, D.C. This unparalleled gathering of patients and caregivers…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through 11 funding opportunities, including the first focused specifically on PCORI…

The Eugene Washington PCORI Engagement Award Program is now accepting applications for the October 2023 Cycle PCORI Funding Announcements (PFAs). The Engagement Award Program supports projects that encourage active, meaningful…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $208 million to support 17 new comparative clinical effectiveness research (CER) studies, including four trials of…

PCORI is introducing a new type of funding opportunity seeking to fund high-quality, comparative clinical effectiveness research (CER) focused on 12 Board-approved Topic Themes. These funding opportunities offered as Topical…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved PCORI investing up to $600 million in patient-centered comparative clinical effectiveness research (CER) through the development…

In response to the increasing crises of over 700 maternal deaths and nearly 73,000 reported cases of maternal morbidity occurring in the United States as recently as 2022, maternal morbidity…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through nine funding opportunities. These PCORI Funding Announcements (PFAs) include four…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $123 million to support 15 new research studies. These studies aim to fill evidence gaps, enhance…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has opened the application periods for nine funding opportunities that offer up to $308.5 million in total funding. The latest PCORI…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $96 million to support 18 new research studies. These studies aim to fill evidence gaps and…

Editor's Note (February 27, 2023) These eight Topic Themes join four that are ongoing—preventing maternal morbidity and mortality, improving outcomes for people with intellectual or developmental disabilities, addressing COVID-19, and…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling $258 million to support 26 new research studies. These studies aim to fill evidence gaps and…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began accepting proposals for new studies and implementation projects through seven funding opportunities. These PCORI Funding Announcements (PFAs) include a…

On May 3, PCORI opened its second funding cycle of the year and started accepting Letters of Intent for several PCORI Funding Announcements (PFAs), which include calls for: Research studies…

Each week throughout April, in recognition of National Minority Health Month, PCORI will spotlight health conditions that disproportionately affect communities of color. One of PCORI's National Priorities for Health is…

Each week throughout April, in recognition of National Minority Health Month, PCORI will spotlight health conditions that disproportionately affect communities of color. One of PCORI's National Priorities for Health is…

WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved several slates of funding awards totaling about $71.5 million to support 12 new comparative clinical effectiveness research (CER)…

Heart disease is widespread and sadly, often deadly. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States. While…

People with cardiovascular disease (CVD) taking aspirin to lower their chances of suffering a heart attack or stroke experienced similar health benefits, including reduced death and hospitalization for heart attack and stroke, whether they took a high or low dose of aspirin, according to a study presented today at ACC.21, the American College of Cardiology’s 70th Annual Scientific Session and published in the New England Journal of Medicine.

More than a dozen topics ranging from healthy aging to prevention of drug addiction among adolescents and from telehealth to addressing bias, racism and discrimination throughout the health care continuum will be the focus of efforts to develop future research funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI) following approval at today’s PCORI Board of Governors meeting.